Maharashtra launches plasma therapy trial programme

Published : June 30, 2020 00:00 IST

Maharashtra Chief Minister Uddhav Thackeray. Photo: Emmanual Yogini

The Maharashtra government launched Project Platina, a plasma therapy trial programme, at the Government Medical College in Nagpur on June 29. The State government said trials would be conducted in 17 medical colleges across Maharashtra. It aims to create a bank of plasma from recovered COVID-19 patients, who would have the antibodies to fight the virus.

Chief Minister Uddhav Thackeray said some 500 patients were under critical care and would be eligible for the treatment. He added that the government plans to scale up the treatment since Maharashtra has been the worst hit by the coronavirus.

The trial and treatment will be free of cost. Thackeray said the project’s estimated cost is Rs.16.65 crore, which would be borne by the Chief Minister’s Relief Fund.

In the absence of a cure for COVID-19, plasma therapy is being used in critical cases and has seen a reasonable success rate. In May, the Indian Council for Medical Research (ICMR) permitted some hospitals to conduct plasma therapy trials, including Nair Hospital and Kasturba Hospital in Mumbai.

A letter from the Editor

Dear reader,

The COVID-19-induced lockdown and the absolute necessity for human beings to maintain a physical distance from one another in order to contain the pandemic has changed our lives in unimaginable ways. The print medium all over the world is no exception.

As the distribution of printed copies is unlikely to resume any time soon, Frontline will come to you only through the digital platform until the return of normality. The resources needed to keep up the good work that Frontline has been doing for the past 35 years and more are immense. It is a long journey indeed. Readers who have been part of this journey are our source of strength.

Subscribing to the online edition, I am confident, will make it mutually beneficial.


R. Vijaya Sankar

Editor, Frontline

Support Quality Journalism
This article is closed for comments.
Please Email the Editor